Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    dermatology

    Cutaneous melanoma

    Also known as: Skin melanoma, Malignant melanoma of the skin, Cutaneous malignant melanoma

    Cutaneous melanoma is a malignant neoplasm of melanocytic origin, characterised by potential for local invasion and distant metastasis. Clinical management—comprising diagnosis, staging, surgical excision, and systemic therapies—requires specialist-led care. In the context of Chinese medicine, practitioners may provide adjunctive support for secondary symptoms such as fatigue, psychological distress, or xerosis; however, suspicious lesions must never be categorised as benign patterns or result in deferred medical investigation. Current research focuses on molecular prognostic markers, in vitro cellular studies, and murine vaccine models; these investigations do not evaluate acupuncture or Chinese herbal medicine in human subjects, nor do they establish clinical efficacy or validate immune-modulatory claims for this malignancy. The TCM patterns described provide a framework for supportive care rather than a treatment for the neoplasm itself. Safety precautions represent general clinical safeguards; the supplied abstracts do not constitute triage or procedural-safety guidelines.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere to the specialist skin-surveillance plan and report any new or changing lesions promptly.
    • •Utilise mechanical sun protection, seek shade, apply broad-spectrum sunscreen, and abstain from artificial ultraviolet radiation exposure.
    • •Ensure adequate nutritional intake and hydration; obtain dietetic consultation if anorexia or unintended weight loss occurs.
    • •Balance restorative rest with tolerated physical exertion and psychosocial support; avoid unverified supplements or nutritionally restrictive 'anticancer' dietary protocols.

    Cautions & Contraindications

    See sources
    • •Do not needle, cup, scrape or apply moxibustion over suspicious lesions, known tumours, infected skin, open wounds or unhealed operative sites. This is a general procedural precaution; source 4 supplies malignancy context, not needling-safety evidence.[]
    • •Defer invasive adjunctive treatment during acute illness or clinically significant cytopenias until the oncology team confirms suitability. Review anticoagulation, lymphoedema and nodal surgery before selecting sites. Source 1 does not establish procedural thresholds.[]
    • •Do not use herbal products to manipulate regulatory T cells or substitute for oncology treatment. Obtain oncology-pharmacist clearance before prescribing, particularly during immunotherapy or targeted therapy; source 2 is mechanistic and provides no herbal-interaction or treatment-safety evidence.[]
    • •Do not represent the experimental vaccine candidate as available supportive treatment or evidence for TCM immune enhancement. Source 3 reports preclinical findings, not established human efficacy or safety.[]

    When to reassess or seek care again

    See sources

    Before adjunctive care, record fatigue, distress, dryness and sleep difficulty on 0–10 scales, alongside sleep duration, appetite and functional activity. Review after 2–4 weeks, or earlier during active systemic treatment. Stop or revise adjunctive care if there is no meaningful symptom benefit or any adverse effect. New lesions, unexplained weight loss, persistent night sweats or deteriorating function require medical review rather than further pattern-based treatment. Oncology surveillance remains unchanged.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Naunyn-Schmiedeberg's archives of pharmacology · 2026
    2. Discover oncology · 2026
    3. Journal of medicinal chemistry · 2026
    4. Pigment cell & melanoma research · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.